Park Dental Partners, Inc. (PARK) AI Stock Analysis

• Market Cap: $69.11M
• Dividend Yield: N/A
• Average Volume (3M): 96.30K
• Price to Earnings (P/E): ―
• Beta (1Y): -0.51
• Revenue Growth: N/A
• EPS Growth: N/A
• Country: US
• Employees: 1,208
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Equipment & Services
• EPS (TTM): N/A
• Shares Outstanding: 4,091,636
• 10 Day Avg. Volume: 61,908
• 30 Day Avg. Volume: 96,297
• PEG Ratio: 0.69
• Price to Book (P/B): 1.32
• Price to Sales (P/S): 0.12
• P/FCF Ratio: 2.79
• Enterprise Value/Market Cap: 384.79
• Enterprise Value/Revenue: 0.11
• Enterprise Value/Gross Profit: 0.79
• Enterprise Value/Ebitda: -89.55
• 1Y Price Target: $22.75
• Price Target Upside: 34.70% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 2
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 62 Neutral
• Price Target: $17.50 ▲(3.61% Upside)
• Action: Reiterated Date: 02/27/26
• Date: Action: Reiterated 02/27/26

The score is held back primarily by weak profitability and balance-sheet risk (historical negative equity/leverage) despite solid and improving cash generation. Technical momentum is supportive (above key moving averages with positive MACD), and the earnings call/guidance is constructive on growth and EBITDA but tempered by higher ongoing costs and dilution-related pressures.

Positive Factors

Consistent positive cash generation

Recurring positive operating cash flow and improving free cash flow provide durable internal funding for capex, working capital and M&A. That persistent cash conversion reduces reliance on equity raises, helps service debt and supports reinvestment even while reported net income is negative.

Improved liquidity and capital access post-IPO

The IPO proceeds plus an extended, undrawn $15M revolver materially strengthen short-term liquidity and the funding runway for disciplined M&A. Reliable capital access and a lower long-term debt balance improve the company's ability to execute growth and absorb integration timing variability.

Organic growth and multi-specialty expansion

Sustained same-practice growth and outsized multi-specialty expansion indicate durable demand, service mix improvement and scalability. Multi-specialty outperformance and geographic additions support higher revenue per practice and create structural upside to margins over time as specialty services scale.

Negative Factors

Persistent negative reported profitability

Negative net income despite positive EBITDA in some periods suggests structural pressure from operating costs, non-cash charges and transaction-related expenses. Continued lack of net profitability constrains retained earnings accumulation and limits the speed at which equity can rebuild.

Historical negative equity and elevated leverage

A history of negative equity and meaningful debt creates balance-sheet risk: covenant sensitivity, higher refinancing costs and limited financial flexibility. The abrupt 2025 equity shift reduces trend comparability and leaves lingering risk that access to debt markets could tighten under stress.

Share-based compensation and public-company cost pressure

Large non-cash compensation and a multi-quarter vesting schedule will keep reported non-cash expenses elevated and increase share count over time, structurally pressuring EPS and reported margins. Ongoing public-company G&A further raises the fixed cost base, reducing near-term profitability headroom.

Park Dental Partners, Inc. Business Overview & Revenue Model

Company Description

Park Dental Partners, Inc. operates as a dental resource organization that offers business support services to dentists throughout Minnesota and Wisconsin. The company's services include provision of clinical team members, administrative personnel, facilities and equipment to affiliated general and multi-specialty dental practitioners. Its network of affiliated dental practices provides both general and specialty dental services, including oral surgery, periodontics, pediatric dentistry, prosthodontics, endodontics, and orthodontics. Park Dental Partners, Inc. was founded in 1972 and is based in Roseville, Minnesota.

How the Company Makes Money

null

Park Dental Partners, Inc. Financial Statement Overview

Summary

Cash flow is consistently positive with improving free cash flow, but profitability remains weak (negative net income) and the balance sheet is high-risk due to historical negative equity and meaningful leverage; large year-to-year statement shifts reduce confidence in the latest trend.

Income Statement

Revenue shows strong growth from 2023 to 2024, but profitability remains weak: net income is negative across the annual periods shown, and net margin stayed below zero. Gross margin is modest and fairly stable (low-to-mid teens). 2024 shows positive EBITDA but negative operating profit and net income, indicating operating costs and/or non-cash/other charges are still pressuring earnings. The 2025 annual datapoint appears inconsistent versus prior years (revenue and growth rate are orders of magnitude larger, with negative EBITDA but near-breakeven operating profit), which reduces confidence in trend quality for the latest period.

Balance Sheet

Leverage is a key concern. In 2023 and 2024, equity is negative, which is a major balance-sheet weakness and makes debt-to-equity difficult to interpret (reported as large negative values). Debt levels are meaningful relative to the business size in those periods, and returns on equity are not reliable given the negative equity base. The 2025 annual datapoint shows positive equity and a more interpretable debt-to-equity (~2.37x), but the step-change versus prior years is large and raises comparability questions. Overall, the balance sheet reads as high-risk due to historical negative equity and elevated leverage.

Cash Flow

Cash generation is a relative bright spot. Operating cash flow is positive in each annual period shown, and free cash flow is also positive each year, improving notably from 2023 to 2024. Cash flow exceeds reported net income (which is negative), suggesting meaningful non-cash expenses and/or working-capital support to cash results. That said, cash flow relative to debt appears only moderate (coverage around ~0.33–0.53x), so leverage still constrains financial flexibility despite positive free cash flow.

Breakdown	Dec 2025	Dec 2024	Dec 2023
Income Statement
Total Revenue	244.49B	229.79M	223.51M
Gross Profit	33.67B	34.13M	27.34M
EBITDA	1.77B	17.50M	10.57M
Net Income	-358.00M	-8.66M	-2.28M
Balance Sheet
Total Assets	178.18B	154.52M	155.12M
Cash, Cash Equivalents and Short-Term Investments	25.18B	2.67M	558.00K
Total Debt	51.74B	62.16M	61.05M
Total Liabilities	156.38M	158.82M	157.41M
Stockholders Equity	21.80B	-4.30M	-2.29M
Cash Flow
Free Cash Flow	10.29B	10.31M	3.83M
Operating Cash Flow	17.63B	16.47M	13.05M
Investing Cash Flow	-10.65B	-7.67M	-14.05M
Financing Cash Flow	15.53B	-6.68M	465.00K

Park Dental Partners, Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
CON	66 Neutral	$2.88B	14.42	46.60%	1.27%	―	―
PARK	62 Neutral	$69.11M	-80.17	―	―	―	―
LH	62 Neutral	$21.79B	23.81	10.28%	1.14%	8.28%	97.24%
NVST	61 Neutral	$4.23B	77.60	1.52%	―	4.73%	―
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
DCGO	50 Neutral	$66.53M	-0.48	-71.45%	―	-47.03%	-274.41%
AMWL	46 Neutral	$95.83M	-0.82	-35.88%	―	4.33%	50.50%

Park Dental Partners, Inc. Corporate Events

Park Dental Amends Credit Facility Following IPO Transition

On February 13, 2026, effective January 1, 2026, Park Dental Partners and its affiliated borrower entities amended their existing credit agreement with U.S. Bank National Association, which provides a $15 million revolving line of credit and a $13 million term loan. The amendment extends the maturity of the revolving facility to March 27, 2029 and is designed to align the company’s financing and reporting structure with its status as a public company following its initial public offering.

Key covenant changes include setting a minimum fixed charge coverage ratio of 1.15 to 1.00, a maximum total cash flow leverage ratio of 4.00 to 1.00, and tightening quarterly financial reporting deadlines to 45 days after quarter-end for most quarters. The amendment also permits the company to extend promissory-note financing to certain doctor shareholders to help cover tax obligations tied to equity vesting at the IPO, potentially supporting shareholder liquidity while maintaining compliance with its lending arrangements.

The most recent analyst rating on (PARK) stock is a Buy with a $22.00 price target. To see the full list of analyst forecasts on Park Dental Partners, Inc. stock, see the PARK Stock Forecast page.

Park Dental Sets 2026 Annual Shareholder Meeting Timeline

On January 29, 2026, Park Dental Partners, Inc. announced that it will hold its 2026 annual shareholder meeting on Friday, May 29, 2026, with the location and time to be disclosed later, and set a deadline of ten days after the press release for shareholders to submit director nominations. The announcement formalizes the company’s governance calendar for 2026 and provides shareholders with a defined window to participate in board nomination processes, reinforcing standard corporate governance practices for the multi-state dental support organization.

The most recent analyst rating on (PARK) stock is a Buy with a $22.00 price target. To see the full list of analyst forecasts on Park Dental Partners, Inc. stock, see the PARK Stock Forecast page.